Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Other

Doseology Sciences rolls out Feed That Brain product

By The Northwire Desk — AI Analysis Mar 04, 2026 · 13:13 MOOD · 0.54 Doseology Sciences Inc
MOOD · Price

Executive Summary

  • Doseology Sciences Inc. has launched "Feed That Brain," a nicotine-free, caffeine-based oral stimulant pouch, initiating its first direct-to-consumer pilot program in the United States.
  • The product is available exclusively via the company's website and Amazon.com, aiming to validate oral pouch delivery as a scalable stimulant platform and evaluate consumer adoption among underserved demographics.
  • The company also announced the granting of restricted and performance share units to a director, aligning compensation with long-term value creation.

Key Details

  • Product Launch: Introduction of "Feed That Brain" energy pouches, a nicotine-free, caffeine-based oral stimulant designed for portion-controlled stimulation without sugar, smoke, or liquid consumption.
  • Distribution Channels: Available exclusively to U.S. consumers on the Feed That Brain website and Amazon.com.
  • Strategic Objective: The U.S. pilot serves to validate oral pouch delivery as a scalable platform, focusing on measuring consumer adoption, usage frequency, and repeat-purchase behavior.
  • Target Market: Focus on underserved demographics seeking alternatives to traditional energy drinks and portable, discreet delivery systems.
  • Executive Quote: Larry Latowsky, Executive Chairman, described the pilot as a "disciplined and deliberate step" to build a scalable oral stimulant platform and generate operational insights for responsible growth.
  • Equity Grant: Granted 140,000 restricted share units (RSUs) and 210,000 performance share units (PSUs) to a company director.
    • RSU Vesting: Equal monthly increments over 36 months from the date of grant.
    • PSU Vesting: Upon achievement of defined performance milestones.

Notable Quotes

  • "This U.S. pilot is a disciplined and deliberate step in Doseology's strategy to build a scalable oral stimulant platform," said Larry Latowsky, executive chairman of Doseology. "Feed That Brain demonstrates how controlled, non-nicotine energy delivery can meet evolving consumer preferences while generating the operational insight required for responsible growth."
Read the original news release →

More from Doseology Sciences Inc

Mar 11, 2026 · 16:48

Doseology shares begin trading on OTCQB Venture Market

Financings Mar 04, 2026 · 07:00

Doseology Launches Feed That Brain(TM) Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot

Other Feb 06, 2026 · 09:32

Why Smart Capital is Ditching Sugar for Science

Production / Operations Jan 29, 2026 · 12:09

Functional Wellness Stocks Explode as $179 Billion Beverage Market Ditches Sugar for Science

Financings Jan 21, 2026 · 15:53

Doseology begins pilot production of energy pouches

Production / Operations Jan 19, 2026 · 12:20

2026 Asset Growth: Why Federal Compliance Is the New Metric

M&A / Property